Research graph
References from Immunohistochemical profile of molecularly verified clear cell renal cell carcinomas. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2022 · External reference
Unresolved reference
External reference
What morphology can teach us about renal cell carcinoma clonal evolution
10.52733/kcj18n3-a1 · 2020 · External reference
10.1016/j.ebiom.2019.10.052
10.1016/j.ebiom.2019.10.052 · External reference
Development and validation of a vascularity‐based architectural classification for clear cell renal cell carcinoma: Correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes
10.1038/s41379-021-00982-9 · 2022 · External reference
10.1016/j.clgc.2022.01.005
10.1016/j.clgc.2022.01.005 · External reference
Architectural patterns are a relevant morphologic grading system for clear cell renal cell carcinoma prognosis assessment: Comparisons with WHO/ISUP grade and integrated staging systems
10.1097/pas.0000000000001025 · 2018 · External reference
10.1016/j.cell.2018.03.043
10.1016/j.cell.2018.03.043 · External reference
10.1097/pas.0b013e318299f0fb
10.1097/pas.0b013e318299f0fb · External reference
The expanding role of BAP1 in clear cell renal cell carcinoma
10.1016/j.humpath.2022.07.022 · 2023 · External reference
New developments in existing WHO entities and evolving molecular concepts: The genitourinary pathology society (GUPS) update on renal neoplasia
10.1038/s41379-021-00779-w · 2021 · External reference
10.1097/pas.0000000000001476
10.1097/pas.0000000000001476 · External reference
10.1097/pas.0000000000000631
10.1097/pas.0000000000000631 · External reference
“Renal cell carcinoma with Leiomyomatous stroma” harbor somatic mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity
10.1097/pas.0000000000001422 · 2020 · External reference
10.1016/j.humpath.2022.12.015
10.1016/j.humpath.2022.12.015 · External reference
10.1016/j.modpat.2025.100777
10.1016/j.modpat.2025.100777 · External reference
Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells
10.1111/his.13791 · 2019 · External reference
10.5858/2007-131-1290-iaocrc
10.5858/2007-131-1290-iaocrc · External reference
10.1007/s00428-003-0948-2
10.1007/s00428-003-0948-2 · External reference
10.1097/01.pas.0000163362.78475.63
10.1097/01.pas.0000163362.78475.63 · External reference
10.1097/pas.0b013e31825b37f0
10.1097/pas.0b013e31825b37f0 · External reference
10.1186/1746-1596-4-21
10.1186/1746-1596-4-21 · External reference
10.1038/s41591-020-0839-y
10.1038/s41591-020-0839-y · External reference
Correlation between molecular subclassifications of clear cell renal cell carcinoma and targeted therapy response
10.1016/j.euf.2015.11.007 · 2016 · External reference
10.1177/10668969231157317
10.1177/10668969231157317 · External reference
10.1038/nature12222
10.1038/nature12222 · External reference
10.1056/nejmoa1505917
10.1056/nejmoa1505917 · External reference
10.1016/j.celrep.2018.03.075
10.1016/j.celrep.2018.03.075 · External reference
10.1093/ajcp/aqaa176
10.1093/ajcp/aqaa176 · External reference
Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms
10.1016/j.humpath.2022.10.009 · 2022 · External reference
MorphoITH: A framework for deconvolving intra‐tumor heterogeneity using tissue morphology
10.1186/s13073-025-01504-x · 2025 · External reference
10.1158/0008-5472.can-21-2318
10.1158/0008-5472.can-21-2318 · External reference
